Use of calcitonin and calcitonin-like peptides to treat and...

Details Use of calcitonin and calcitonin-like peptides to treat and... Use of calcitonin and calcitonin-like peptides to treat and...

2007-12-07

2010-06-29

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600

Reexamination Certificate

active

07745404

ABSTRACT:
Methods for treating and preventing multiple sclerosis by administering to a patient an effective amount of calcitonin, calcitonin-like peptides or calcitonin mimetics to a patient. Additionally, 1,25-dihydroxyvitamin D analogs can be used in combination with the calcitonin, calcitonin-like peptides or calcitonin mimetics.

REFERENCES:
patent: 5614513 (1997-03-01), Knutson
patent: 5716946 (1998-02-01), DeLuca
patent: 5831000 (1998-11-01), Murayama
patent: 7048906 (2006-05-01), Lin
patent: 7259143 (2007-08-01), DeLuca et al.
patent: 2003/0207847 (2003-11-01), DeLuca
patent: 2004/0053813 (2004-03-01), DeLuca
patent: 2004/0146549 (2004-07-01), Ben-Sasson
patent: 2004/0156826 (2004-08-01), Dangond
patent: 2005/0009742 (2005-01-01), Bertilsson
patent: 719773 (2000-05-01), None
Rudinger, Peptide Hormones, JA Parsons, 1976, 1-7.
T-Hart, DDT, 2004, 9(12), pp. 517-524.
Lazar, Molecular and Cellular Biology, 1988, 8(3), pp. 1247-1252.

Affiliated with

Also associated with

Rating

Use of calcitonin and calcitonin-like peptides to treat and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of calcitonin and calcitonin-like peptides to treat and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of calcitonin and calcitonin-like peptides to treat and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4244276